2015
DOI: 10.3126/ajms.v6i4.11659
|View full text |Cite
|
Sign up to set email alerts
|

Strengthening adverse drug reaction reporting in Nepal

Abstract: Pharmacovigilance in Nepal is still in infancy. Till date only healthcare professionals are involved and the problem of underreporting is seen. The national pharmacovigilance centre is located in the national regulatory authority of Nepal, i.e. Department of Drug Administration (DDA). Lack of adequate human resources for managing the pharmacovigilance program in Nepal has been a limitation for the growth of pharmacovigilance activities. Currently, there is neither any involvement of community pharmacists in Ad… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…12,13 However, underreporting of ADR is widely prevalent in Nepal. [14][15][16] In the context of Nepal, it is not mandatory for HCPs working at different hospitals to report ADR to either regional pharmacovigilance center or national pharmacovigilance center.…”
Section: Introductionmentioning
confidence: 99%
“…12,13 However, underreporting of ADR is widely prevalent in Nepal. [14][15][16] In the context of Nepal, it is not mandatory for HCPs working at different hospitals to report ADR to either regional pharmacovigilance center or national pharmacovigilance center.…”
Section: Introductionmentioning
confidence: 99%
“…In addition to this conducting sensitization programs on reporting systems at various conferences and workshops may also enhance the reporting rate. (Jha et al,2015)expressed his view on strengthening reporting rate by implementing few strategies like regular sensitizing on reporting to healthcare staff, and enhancing motivation in terms of reporting. They also opined on awarding or rewarding to reporters which may tackle the www.jpadr.com m underreporting.…”
Section: Discussionmentioning
confidence: 99%
“…The national pharmacovigilance centre coordinates with seven centres in Nepal of which five are situated in the Kathmandu valley. These centres collect ADR reports from health care professionals and forward them to the Department of Drug Administration (DDA) in Kathmandu from where the reports are sent to the Uppsala Monitoring Centre in Sweden which serves as a centre for international service and scientific research towards patient safety using an online program called Vigiflow [7]. Underreporting of ADR is widely prevalent in Nepal [8].…”
Section: Introduction mentioning
confidence: 99%